ENTRY       D12325                      Drug
NAME        Ogalvibart (USAN/INN)
FORMULA     C6450H9934N1718O2012S42
EXACT_MASS  144993.6102
MOL_WEIGHT  145082.9244
SEQUENCE    (Heavy chain)
            QVQLVESGGG VVQPGRSLRL SCAASGFTFS SYAMHWVRQA PGKGLEWVAV IPFDGRNKYY
            ADSVTGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCASSS GYLFHSDYWG QGTLVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKRVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSREEM
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVL HEALHSHYTQ KSLSLSPG
            (Light chain)
            DIQMTQSPST LSASVGDRVT ITCRASQSIS NWLAWFQQKP GKAPKLLIYE ASSLESGVPS
            RFSGSGSGTE FTLTISSLQP DDFATYYCQQ YNSYPWTFGQ GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H146-H202, H222-L214, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'214, H'263-H'323, H'369-H'427, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
CLASS       Antiviral
             DG03174  Anti-SARS-CoV-2 agent
EFFICACY    Antiviral
  TYPE      Monoclonal antibody
COMMENT     Treatment of SARS-CoV-2 infection
TARGET      SARS-CoV-2 spike glycoprotein [KO:K24152]
  PATHWAY   ko03230(K24152)  Viral genome structure
            ko05171(K24152)  Coronavirus disease - COVID-19
BRITE       Drug groups [BR:br08330]
             Antiviral
              DG03174  Anti-SARS-CoV-2 agent
               D12325  Ogalvibart
            Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Coronavirus spike protein
                D12325  Ogalvibart (USAN/INN)
DBLINKS     CAS: 2599039-60-6
///
